# Shree Ganesh Remedies Ltd (SGRL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹575.6
Day Change: +15.49%
52W High: ₹794
52W Low: ₹381.1
Market Cap: ₹739 Cr

## Valuation
P/E: 40.82
P/B: 4.81
EPS: ₹14.1
Book Value: ₹119.59
Dividend Yield: 0%

## Returns
1Y Return: -23.91%

## Profitability
ROE: 18.7%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Shree Ganesh Remedies Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Shree Ganesh Remedies Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

## Access
Current tier: anonymous
More history: Register free to see 2 more years.

## Data Freshness
Quote Updated: 2026-05-17T00:10:13.676Z
Price History Updated: 2026-05-18T22:59:15.839Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-18T22:59:15.839Z
Quant Updated: 2026-05-18T22:59:15.839Z
Sentiment Updated: 2026-05-18T22:59:15.839Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:01.379Z
Financials Last Attempt: 2026-05-18T10:30:01.379Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2020)
Revenue: ₹35 Cr
Operating Profit: ₹9 Cr (OPM 25%)
Net Profit: ₹6 Cr
Tax: ₹9 Cr

## Annual P&L History
Mar 2020: Rev ₹35Cr | PAT ₹6Cr | OPM 25%
Mar 2021: Rev ₹64Cr | PAT ₹10Cr | OPM 20%
Mar 2024: Rev ₹49Cr | PAT ₹10Cr | OPM 28%

## Balance Sheet (Mar 2020)
Total Assets: ₹41 Cr
Total Liabilities: ₹41 Cr
Borrowings: ₹1 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/sgrl
Disclaimer: For research and education only. Not investment advice.